Jump to content

News articles

Amaia Zurutuza, Chief Scientific Officer of Graphenea
Production / 2D-PL / Standardisation

Quality Control in Graphene Manufacturing


Amaia Zurutuza, Chief Scientific Officer at Graphene Flagship partner Graphenea shaes her thoughts on what truly defines high-quality graphene, why reproducibility matters more than peak performance, and how industrial customers should evaluate suppliers.

By Graphene Flagship / 15 July 2026
KCANIA accepted as Graphene Flagship Associate Member
Our project / Collaboration

Graphene Flagship accepts first overseas Associate Member


The Korea Carbon Nano Industry Association (KCANIA) celebrated its acceptance as the Graphene Flagship's first overseas Associate Member at the Global Graphene Commercialization Summit 2026 hosted by South Korea's Ministry of Trade, Industry and Energy at the Korea Science and Technology Centre in Seoul.

By Graphene Flagship / 08 July 2026
Sina Dörr  Impact Leader Graphene Week 2025
Diversity / Sustainability / Energy

Spotlight: Sina Dörr


Sina Dörr, a PhD student at the University of Kassel, won the Impact Leader Award at Graphene Week 2025 in Vicenza, Italy. She now shares with us her thoughts on 2D materials and explains her research using transition metal dichalcogenides to improve raindrop triboelectric nanogenerators.

By Graphene Flagship / 01 July 2026
artificial retina
Biomedical / Innovation / Milestones

Graphene oxide added to the composition of the liquid artificial retina: A further step toward clinical trials


Graphene Flagship partner, the Istituto Italiano di Tecnologia, together with IRCCS Azienda Ospedaliera Metropolitana – Policlinico San Martino Hospital, has demonstrated that graphene oxide—used for the first time in the ophthalmic field—enhances the liquid artificial retina, increasing light sensitivity and recovery of visual function in advanced stages of retinitis pigmentosa. The study, published in Nature Communications, led to the restoration of electrical activity in the visual cortex, bringing this strategy closer to future clinical trials in humans.

By Graphene Flagship / 13 May 2026